Ausgabe 2/2024
Inhalt (10 Artikel)
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, Yuichi Ando, Sumio Hirata, Kent Doi, Yutaka Fujiwara, Norio Hanafusa, Takahiro Hatta, Junichi Hoshino, Satoko Ichioka, Takamitsu Inoue, Kenji Ishikura, Taigo Kato, Hiroshi Kitamura, Yusuke Kobayashi, Yuichi Koizumi, Chihiro Kondoh, Takeshi Matsubara, Kazuo Matsubara, Koji Matsumoto, Yusuke Okuda, Yuta Okumura, Emiko Sakaida, Yugo Shibagaki, Hideki Shimodaira, Nao Takano, Akiko Uchida, Kimikazu Yakushijin, Takehito Yamamoto, Kazuhiro Yamamoto, Yoshinari Yasuda, Mototsugu Oya, Hirokazu Okada, Masaomi Nangaku, Naoki Kashihara
Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
Motoko Yanagita, Satoru Muto, Hiroyuki Nishiyama, Yuichi Ando, Sumio Hirata, Kent Doi, Yutaka Fujiwara, Norio Hanafusa, Takahiro Hatta, Junichi Hoshino, Satoko Ichioka, Takamitsu Inoue, Kenji Ishikura, Taigo Kato, Hiroshi Kitamura, Yusuke Kobayashi, Yuichi Koizumi, Chihiro Kondoh, Takeshi Matsubara, Kazuo Matsubara, Koji Matsumoto, Yusuke Okuda, Yuta Okumura, Emiko Sakaida, Yugo Shibagaki, Hideki Shimodaira, Nao Takano, Akiko Uchida, Kimikazu Yakushijin, Takehito Yamamoto, Kazuhiro Yamamoto, Yoshinari Yasuda, Mototsugu Oya, Hirokazu Okada, Masaomi Nangaku, Naoki Kashihara
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
Xinping Chen, Xuan Li, Kexin Zhang, Kexin Lian, Wenqiang Zhang, Yixin Song, Chengxia Kan, Jingwen Zhang, Fang Han, Xiaodong Sun, Zhentao Guo
Alleviation effects of epigallocatechin-3-gallate against acute kidney injury following severe burns
Hongyan Xu, Yichao Pang, Wei Sun, Yi Luo
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m2 in the J-DREAMS cohort
Yuka Sugawara, Eiichiro Kanda, Mitsuru Ohsugi, Kohjiro Ueki, Naoki Kashihara, Masaomi Nangaku
Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial
Masaaki Nakayama, Shuhei Kobayashi, Miho Kusakabe, Meiko Ohara, Kaoru Nakanishi, Tadao Akizawa, Masafumi Fukagawa
Survival benefit of living donor kidney transplantation in patients on hemodialysis
Shunsuke Goto, Hideki Fujii, Makiko Mieno, Takashi Yagisawa, Masanori Abe, Kosaku Nitta, Shinichi Nishi
Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment
Jun Matsumoto, Yosuke Saka, Tomohiko Naruse
Correction to: Efficacy and safety of entecavir for hepatitis B virus-associated glomerulonephritis with renal insufficiency
Yani Yu, Lingyu Xu, Ting Xu, Chengyu Yang, Quandong Bu, Wei Zhang, Long Zhao, Yan Xu, Wei Jiang